Director/PDMR Shareholding

GlaxoSmithKline PLC
24 October 2006





   Notification of Transactions of Directors, Persons Discharging Managerial
                      Responsibility or Connected Persons



I give below details of changes in the interests of Directors, Persons
Discharging Managerial Responsibility or Connected Persons in the Ordinary
Shares of GlaxoSmithKline plc.


   24 October 2006               Abacus Corporate Trustees Limited, as trustee of the
                                 GlaxoSmithKline (US) Trust, ("the GSK US Trust"), sold 2,225
                                 Ordinary Share ADRs in the Company on behalf of participants in
                                 the GlaxoSmithKline Share Value Plan at a price of $55.65 per
                                 ADR.


                                 The GSK US Trust transferred 4,968 Ordinary Share ADRs in the
                                 Company to participants in the GlaxoSmithKline Share Value
                                 Plan.



The Company was advised of these transactions on 24 October 2006.



The GSK US Trust is a grantor trust of which all employees or former employees
of SmithKline Beecham Corporation and its subsidiaries are potential
beneficiaries. Two of the Company's directors, Dr J-P Garnier and Dr M M Slaoui
are therefore interested in the shares held in the GSK US Trust from time to
time in the same way as other employees or former employees of SmithKline
Beecham Corporation and its subsidiaries.



This notification relates to a transaction notified in accordance with
Disclosure Rule 3.1.4R(1)(b).







S M Bicknell

Company Secretary



24 October 2006


                      This information is provided by RNS
            The company news service from the London Stock Exchange       DSDZLFLQBBEFBV